Quantification of Extracellular Matrix Expansion by CMR in Infiltrative Heart Disease
The aim of this study was to perform direct quantification of myocardial extracellular volume fraction (ECF) with T1-weighted cardiac magnetic resonance (CMR) imaging in patients suspected to have infiltrative heart disease. Infiltrative heart disease refers to accumulation of abnormal substances wi...
Saved in:
Published in | JACC. Cardiovascular imaging Vol. 5; no. 9; pp. 897 - 907 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.09.2012
|
Subjects | |
Online Access | Get full text |
ISSN | 1936-878X 1876-7591 1876-7591 |
DOI | 10.1016/j.jcmg.2012.04.006 |
Cover
Abstract | The aim of this study was to perform direct quantification of myocardial extracellular volume fraction (ECF) with T1-weighted cardiac magnetic resonance (CMR) imaging in patients suspected to have infiltrative heart disease.
Infiltrative heart disease refers to accumulation of abnormal substances within the myocardium. Qualitative assessment of late gadolinium enhancement (LGE) remains the most commonly used method for CMR evaluation of patients suspected with myocardial infiltration. This technique is widely available and can be performed in a reproducible and standardized manner. However, the degree of extracellular matrix expansion due to myocardial infiltration in the intercellular space has, to date, not been amenable to noninvasive quantification with LGE.
We performed 3-T CMR in 38 patients (mean age 68 ± 15 years) who were referred for assessment of infiltrative heart disease and also in 9 healthy volunteers as control subjects. The T1 quantification by Look-Locker gradient-echo before and after contrast determined segmental myocardial partition coefficients. The ECF was obtained by referencing the tissue partition coefficient for gadolinium to the plasma volume fraction in blood, derived from serum hematocrit. Cine CMR and LGE imaging in matching locations were also performed.
Seventeen patients (45%) had cardiac amyloidosis (CA) (biopsy-confirmed or clinically highly probable), 20 (53%) had a non-amyloid cardiomyopathy, and 1 had lysosomal storage disease. Median global ECF was substantially higher in CA patients (0.49) compared with non-amyloid cardiomyopathy patients (0.33, p < 0.0001) and volunteers (0.24, p = 0.0001). The ECF strongly correlated with visually assessed segmental LGE (r = 0.80, p < 0.0001) and LV mass index (r = 0.69, p < 0.0001), reflecting severity of myocardial infiltration. In patients with CA, ECF was highest in segments with LGE, although it remained elevated in segments without qualitative LGE.
The CMR ECF quantification identified substantial expansion of the interstitial space in patients with CA compared with volunteers. Further studies using this technique for diagnosis and assessment of the severity of myocardial infiltration are warranted. |
---|---|
AbstractList | Objectives The aim of this study was to perform direct quantification of myocardial extracellular volume fraction (ECF) with T1-weighted cardiac magnetic resonance (CMR) imaging in patients suspected to have infiltrative heart disease. Background Infiltrative heart disease refers to accumulation of abnormal substances within the myocardium. Qualitative assessment of late gadolinium enhancement (LGE) remains the most commonly used method for CMR evaluation of patients suspected with myocardial infiltration. This technique is widely available and can be performed in a reproducible and standardized manner. However, the degree of extracellular matrix expansion due to myocardial infiltration in the intercellular space has, to date, not been amenable to noninvasive quantification with LGE. Methods We performed 3-T CMR in 38 patients (mean age 68 ± 15 years) who were referred for assessment of infiltrative heart disease and also in 9 healthy volunteers as control subjects. The T1 quantification by Look-Locker gradient-echo before and after contrast determined segmental myocardial partition coefficients. The ECF was obtained by referencing the tissue partition coefficient for gadolinium to the plasma volume fraction in blood, derived from serum hematocrit. Cine CMR and LGE imaging in matching locations were also performed. Results Seventeen patients (45%) had cardiac amyloidosis (CA) (biopsy-confirmed or clinically highly probable), 20 (53%) had a non-amyloid cardiomyopathy, and 1 had lysosomal storage disease. Median global ECF was substantially higher in CA patients (0.49) compared with non-amyloid cardiomyopathy patients (0.33, p < 0.0001) and volunteers (0.24, p = 0.0001). The ECF strongly correlated with visually assessed segmental LGE (r = 0.80, p < 0.0001) and LV mass index (r = 0.69, p < 0.0001), reflecting severity of myocardial infiltration. In patients with CA, ECF was highest in segments with LGE, although it remained elevated in segments without qualitative LGE. Conclusions The CMR ECF quantification identified substantial expansion of the interstitial space in patients with CA compared with volunteers. Further studies using this technique for diagnosis and assessment of the severity of myocardial infiltration are warranted. The aim of this study was to perform direct quantification of myocardial extracellular volume fraction (ECF) with T1-weighted cardiac magnetic resonance (CMR) imaging in patients suspected to have infiltrative heart disease.OBJECTIVESThe aim of this study was to perform direct quantification of myocardial extracellular volume fraction (ECF) with T1-weighted cardiac magnetic resonance (CMR) imaging in patients suspected to have infiltrative heart disease.Infiltrative heart disease refers to accumulation of abnormal substances within the myocardium. Qualitative assessment of late gadolinium enhancement (LGE) remains the most commonly used method for CMR evaluation of patients suspected with myocardial infiltration. This technique is widely available and can be performed in a reproducible and standardized manner. However, the degree of extracellular matrix expansion due to myocardial infiltration in the intercellular space has, to date, not been amenable to noninvasive quantification with LGE.BACKGROUNDInfiltrative heart disease refers to accumulation of abnormal substances within the myocardium. Qualitative assessment of late gadolinium enhancement (LGE) remains the most commonly used method for CMR evaluation of patients suspected with myocardial infiltration. This technique is widely available and can be performed in a reproducible and standardized manner. However, the degree of extracellular matrix expansion due to myocardial infiltration in the intercellular space has, to date, not been amenable to noninvasive quantification with LGE.We performed 3-T CMR in 38 patients (mean age 68 ± 15 years) who were referred for assessment of infiltrative heart disease and also in 9 healthy volunteers as control subjects. The T1 quantification by Look-Locker gradient-echo before and after contrast determined segmental myocardial partition coefficients. The ECF was obtained by referencing the tissue partition coefficient for gadolinium to the plasma volume fraction in blood, derived from serum hematocrit. Cine CMR and LGE imaging in matching locations were also performed.METHODSWe performed 3-T CMR in 38 patients (mean age 68 ± 15 years) who were referred for assessment of infiltrative heart disease and also in 9 healthy volunteers as control subjects. The T1 quantification by Look-Locker gradient-echo before and after contrast determined segmental myocardial partition coefficients. The ECF was obtained by referencing the tissue partition coefficient for gadolinium to the plasma volume fraction in blood, derived from serum hematocrit. Cine CMR and LGE imaging in matching locations were also performed.Seventeen patients (45%) had cardiac amyloidosis (CA) (biopsy-confirmed or clinically highly probable), 20 (53%) had a non-amyloid cardiomyopathy, and 1 had lysosomal storage disease. Median global ECF was substantially higher in CA patients (0.49) compared with non-amyloid cardiomyopathy patients (0.33, p < 0.0001) and volunteers (0.24, p = 0.0001). The ECF strongly correlated with visually assessed segmental LGE (r = 0.80, p < 0.0001) and LV mass index (r = 0.69, p < 0.0001), reflecting severity of myocardial infiltration. In patients with CA, ECF was highest in segments with LGE, although it remained elevated in segments without qualitative LGE.RESULTSSeventeen patients (45%) had cardiac amyloidosis (CA) (biopsy-confirmed or clinically highly probable), 20 (53%) had a non-amyloid cardiomyopathy, and 1 had lysosomal storage disease. Median global ECF was substantially higher in CA patients (0.49) compared with non-amyloid cardiomyopathy patients (0.33, p < 0.0001) and volunteers (0.24, p = 0.0001). The ECF strongly correlated with visually assessed segmental LGE (r = 0.80, p < 0.0001) and LV mass index (r = 0.69, p < 0.0001), reflecting severity of myocardial infiltration. In patients with CA, ECF was highest in segments with LGE, although it remained elevated in segments without qualitative LGE.The CMR ECF quantification identified substantial expansion of the interstitial space in patients with CA compared with volunteers. Further studies using this technique for diagnosis and assessment of the severity of myocardial infiltration are warranted.CONCLUSIONSThe CMR ECF quantification identified substantial expansion of the interstitial space in patients with CA compared with volunteers. Further studies using this technique for diagnosis and assessment of the severity of myocardial infiltration are warranted. The aim of this study was to perform direct quantification of myocardial extracellular volume fraction (ECF) with T1-weighted cardiac magnetic resonance (CMR) imaging in patients suspected to have infiltrative heart disease. Infiltrative heart disease refers to accumulation of abnormal substances within the myocardium. Qualitative assessment of late gadolinium enhancement (LGE) remains the most commonly used method for CMR evaluation of patients suspected with myocardial infiltration. This technique is widely available and can be performed in a reproducible and standardized manner. However, the degree of extracellular matrix expansion due to myocardial infiltration in the intercellular space has, to date, not been amenable to noninvasive quantification with LGE. We performed 3-T CMR in 38 patients (mean age 68 ± 15 years) who were referred for assessment of infiltrative heart disease and also in 9 healthy volunteers as control subjects. The T1 quantification by Look-Locker gradient-echo before and after contrast determined segmental myocardial partition coefficients. The ECF was obtained by referencing the tissue partition coefficient for gadolinium to the plasma volume fraction in blood, derived from serum hematocrit. Cine CMR and LGE imaging in matching locations were also performed. Seventeen patients (45%) had cardiac amyloidosis (CA) (biopsy-confirmed or clinically highly probable), 20 (53%) had a non-amyloid cardiomyopathy, and 1 had lysosomal storage disease. Median global ECF was substantially higher in CA patients (0.49) compared with non-amyloid cardiomyopathy patients (0.33, p < 0.0001) and volunteers (0.24, p = 0.0001). The ECF strongly correlated with visually assessed segmental LGE (r = 0.80, p < 0.0001) and LV mass index (r = 0.69, p < 0.0001), reflecting severity of myocardial infiltration. In patients with CA, ECF was highest in segments with LGE, although it remained elevated in segments without qualitative LGE. The CMR ECF quantification identified substantial expansion of the interstitial space in patients with CA compared with volunteers. Further studies using this technique for diagnosis and assessment of the severity of myocardial infiltration are warranted. |
Author | Falk, Rodney H. Blankstein, Ron Coelho-Filho, Otávio Rizzi Jerosch-Herold, Michael Kwong, Raymond Y. Mongeon, François-Pierre |
AuthorAffiliation | Department of Internal Medicine, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil Noninvasive Cardiology Service, Department of Medicine, Montreal Heart Institute, Université de Montréal, Montreal, Quebec, Canada Cardiovascular Division, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts Department of Radiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts |
AuthorAffiliation_xml | – name: Cardiovascular Division, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts – name: Department of Internal Medicine, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil – name: Department of Radiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts – name: Noninvasive Cardiology Service, Department of Medicine, Montreal Heart Institute, Université de Montréal, Montreal, Quebec, Canada |
Author_xml | – sequence: 1 givenname: François-Pierre surname: Mongeon fullname: Mongeon, François-Pierre organization: Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts – sequence: 2 givenname: Michael surname: Jerosch-Herold fullname: Jerosch-Herold, Michael organization: Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts – sequence: 3 givenname: Otávio Rizzi surname: Coelho-Filho fullname: Coelho-Filho, Otávio Rizzi organization: Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts – sequence: 4 givenname: Ron surname: Blankstein fullname: Blankstein, Ron organization: Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts – sequence: 5 givenname: Rodney H. surname: Falk fullname: Falk, Rodney H. organization: Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts – sequence: 6 givenname: Raymond Y. surname: Kwong fullname: Kwong, Raymond Y. email: rykwong@partners.org organization: Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22974802$$D View this record in MEDLINE/PubMed |
BookMark | eNp9Ustu1DAUtVARfcAPsEBZskmwHSd2WCChodBKrRCPSuyuPM518ZCxp3Yy6vw9Dp0iQKIrW_Z5-J7jY3Lgg0dCnjNaMcraV6tqZdbXFaeMV1RUlLaPyBFTsi1l07GDvO_qtlRSfTskxymtMoC2Qj4hh5x3UijKj8jVp0n70Vln9OiCL4ItTm_HqA0OwzToWFzqMbrbfLjRPs2I5a5YXH4unC_OvXVDxo5ui8UZ6jgW71xCnfApeWz1kPDZfj0hV-9Pvy7OyouPH84Xby9K00gxllawrqGG2qWkVItetW3dcKWtRaM6ZlGqXlqz7A1nHa37ptGCWSEldrpnyOoT8uZOdzMt19gb9Pk5A2yiW-u4g6Ad_H3j3Xe4Dluou0Y0VGSBl3uBGG4mTCOsXZpn1x7DlIDRulNK5FAz9MWfXr9N7rPMAHUHMDGkFNGCceOvVLO1G7IWzLXBCubaYK4NqIDcSqbyf6j36g-S9sNjTnjrMIIZnM9FDj9wh2kVpuhz-MAgZQ58mX_D_BkYp7SpeZ0FXv9fAPrgHnL_Cb2axr0 |
CitedBy_id | crossref_primary_10_1016_j_jcmg_2015_05_014 crossref_primary_10_1016_j_jcmg_2015_11_002 crossref_primary_10_1177_2047487319877708 crossref_primary_10_1186_s12872_018_0952_8 crossref_primary_10_15829_1560_4071_2023_5259 crossref_primary_10_2478_ahp_2018_0002 crossref_primary_10_1016_j_jacc_2013_08_002 crossref_primary_10_1016_j_jcmg_2013_05_005 crossref_primary_10_1136_heartjnl_2022_321115 crossref_primary_10_1016_j_rx_2015_12_007 crossref_primary_10_1002_jmri_25720 crossref_primary_10_1016_j_tcm_2017_07_004 crossref_primary_10_1161_CIRCULATIONAHA_115_016567 crossref_primary_10_1055_a_1334_8434 crossref_primary_10_3348_kjr_2017_18_1_113 crossref_primary_10_1007_s11886_024_02114_6 crossref_primary_10_1016_j_cardfail_2017_08_445 crossref_primary_10_1016_j_jcmg_2012_10_030 crossref_primary_10_1002_ehf2_12565 crossref_primary_10_1007_s10554_018_1385_2 crossref_primary_10_1148_rg_346140030 crossref_primary_10_1016_j_jcmg_2015_11_005 crossref_primary_10_1161_JAHA_113_000279 crossref_primary_10_3390_biomedicines13010079 crossref_primary_10_1007_s11864_020_00738_8 crossref_primary_10_1007_s11886_019_1097_9 crossref_primary_10_1007_s10554_018_1320_6 crossref_primary_10_3389_fcvm_2024_1359657 crossref_primary_10_2174_1381612829666221212100114 crossref_primary_10_2147_VHRM_S295376 crossref_primary_10_1161_CIRCULATIONAHA_115_019949 crossref_primary_10_1007_s00330_017_4845_5 crossref_primary_10_1161_CIRCIMAGING_113_000178 crossref_primary_10_1097_CRD_0000000000000695 crossref_primary_10_1093_eurheartj_ehu444 crossref_primary_10_1186_s12968_020_00622_2 crossref_primary_10_17996_anc_20_00130 crossref_primary_10_1371_journal_pone_0263378 crossref_primary_10_1016_j_jcmg_2012_11_013 crossref_primary_10_1093_ehjopen_oead092 crossref_primary_10_1155_2022_3094933 crossref_primary_10_1007_s12350_013_9800_5 crossref_primary_10_1161_HCI_0000000000000081 crossref_primary_10_1186_s12872_016_0311_6 crossref_primary_10_1136_openhrt_2017_000717 crossref_primary_10_1093_ehjci_jeaa310 crossref_primary_10_1007_s10741_014_9470_7 crossref_primary_10_1161_CIRCIMAGING_116_003951 crossref_primary_10_1186_1532_429X_15_92 crossref_primary_10_1161_CIRCIMAGING_113_001396 crossref_primary_10_1016_j_mric_2014_08_007 crossref_primary_10_1007_s40119_013_0017_0 crossref_primary_10_1016_j_repc_2021_04_005 crossref_primary_10_1016_j_jacc_2013_10_084 crossref_primary_10_1586_14779072_2015_1093936 crossref_primary_10_1159_000478901 crossref_primary_10_1148_radiol_2016141802 crossref_primary_10_1016_j_crad_2020_09_023 crossref_primary_10_1007_s10741_018_9718_8 crossref_primary_10_1007_s12410_017_9416_2 crossref_primary_10_1016_j_jcmg_2013_12_002 crossref_primary_10_3389_fcvm_2022_830572 crossref_primary_10_1016_j_jcmg_2019_06_023 crossref_primary_10_1161_CIRCULATIONAHA_115_018832 crossref_primary_10_1186_1532_429X_14_90 crossref_primary_10_1007_s12350_015_0149_9 crossref_primary_10_1007_s12410_017_9399_z crossref_primary_10_1016_j_mri_2014_08_023 crossref_primary_10_1016_j_rxeng_2016_05_004 crossref_primary_10_1002_ehf2_12511 crossref_primary_10_1007_s11886_021_01564_6 crossref_primary_10_1016_j_jcmg_2012_04_007 crossref_primary_10_1016_j_echo_2019_09_022 crossref_primary_10_1016_j_hfc_2018_12_007 crossref_primary_10_1007_s10554_015_0595_0 crossref_primary_10_1016_j_jcmg_2024_05_004 crossref_primary_10_1161_CIRCIMAGING_120_010785 crossref_primary_10_1186_s12968_015_0181_6 crossref_primary_10_1016_j_jacc_2016_02_018 crossref_primary_10_1586_14779072_2014_876363 crossref_primary_10_1016_j_jcmg_2020_02_025 crossref_primary_10_1186_s12968_017_0419_6 crossref_primary_10_15212_CVIA_2016_0066 crossref_primary_10_1007_s13244_014_0366_9 crossref_primary_10_1016_j_amjcard_2012_11_022 crossref_primary_10_1016_j_jacc_2014_01_068 crossref_primary_10_1002_jmri_27459 crossref_primary_10_1007_s11936_017_0500_3 crossref_primary_10_36660_abc_20210718 crossref_primary_10_1016_j_mric_2019_04_007 crossref_primary_10_3390_jpm14040407 crossref_primary_10_57187_s_4186 crossref_primary_10_1007_s11936_016_0469_3 crossref_primary_10_3390_bioengineering10030345 crossref_primary_10_1093_ehjci_jead350 crossref_primary_10_1161_CIRCIMAGING_124_017475 crossref_primary_10_2459_JCM_0000000000001695 crossref_primary_10_1016_j_jcmg_2013_08_015 crossref_primary_10_1016_j_jcmg_2019_07_015 crossref_primary_10_1016_j_recesp_2016_04_036 crossref_primary_10_1007_s12350_015_0235_z crossref_primary_10_1016_j_jcmg_2013_01_007 crossref_primary_10_1186_s12880_015_0099_3 crossref_primary_10_1007_s10741_016_9580_5 crossref_primary_10_3390_ph15091145 crossref_primary_10_1016_j_jcmg_2013_08_013 crossref_primary_10_1016_j_jcmg_2023_10_010 crossref_primary_10_31083_j_rcm_2021_01_134 crossref_primary_10_1161_CIRCULATIONAHA_114_009362 crossref_primary_10_1002_mrm_28675 crossref_primary_10_1007_s40119_022_00299_x crossref_primary_10_1016_j_rec_2016_04_045 crossref_primary_10_1186_s12968_018_0478_3 |
Cites_doi | 10.1002/mrm.20110 10.1016/0002-9149(82)90270-3 10.1016/j.jacc.2010.11.013 10.1016/j.jacc.2008.06.049 10.1016/j.jacc.2008.08.064 10.1016/j.amjcard.2004.04.026 10.1161/01.CIR.0000152819.97857.9D 10.1016/j.jacc.2009.12.040 10.1056/NEJMoa033349 10.1148/radiology.211.3.r99jn41698 10.1002/mrm.20830 10.1016/j.jacc.2009.04.094 10.2214/AJR.08.1201 10.1016/j.jacc.2007.10.049 10.1002/mrm.20236 10.1152/ajpheart.00429.2008 10.1186/1756-6649-9-5 10.1161/CIRCULATIONAHA.109.930636 10.1186/1532-429X-13-16 10.1148/radiology.218.3.r01fe18703 10.1016/j.jcmg.2009.09.023 10.1186/1532-429X-11-12 10.1186/1532-429X-10-54 10.1016/j.pcad.2009.11.007 10.1016/j.amjcard.2008.09.105 10.1161/CIRCIMAGING.108.842096 10.1080/13506120802193233 10.1016/j.jcmg.2009.08.008 |
ContentType | Journal Article |
Copyright | 2012 American College of Cardiology Foundation American College of Cardiology Foundation Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. 2012 by the American College of Cardiology Foundation 2012 |
Copyright_xml | – notice: 2012 American College of Cardiology Foundation – notice: American College of Cardiology Foundation – notice: Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. – notice: 2012 by the American College of Cardiology Foundation 2012 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1016/j.jcmg.2012.04.006 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1876-7591 |
EndPage | 907 |
ExternalDocumentID | PMC3954504 22974802 10_1016_j_jcmg_2012_04_006 1_s2_0_S1936878X12005323 S1936878X12005323 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: National Institutes of Health grantid: R01HL091157 – fundername: National Institutes of Health grantid: R01HL090634-01A1 – fundername: NHLBI NIH HHS grantid: R01HL091157 – fundername: NHLBI NIH HHS grantid: R01HL090634-01A1 – fundername: NHLBI NIH HHS grantid: R01 HL091157 |
GroupedDBID | --- --K --M .1- .FO .~1 0R~ 18M 1B1 1P~ 1~. 4.4 457 4G. 53G 5GY 5VS 7-5 8P~ AAEDT AAEDW AAIKJ AALRI AAOAW AAQFI AAXUO AAYWO ABBQC ABFRF ABJNI ABMAC ABMZM ABWVN ABXDB ACGFO ACGFS ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADVLN AEFWE AEKER AEUPX AEVXI AEXQZ AFJKZ AFPUW AFRHN AFTJW AGCQF AGHFR AGYEJ AIGII AITUG AJRQY AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ APXCP BAWUL BLXMC CS3 DIK E3Z EBS EFKBS EJD F5P FDB FEDTE FNPLU GBLVA H13 HVGLF HZ~ IXB J1W M41 MO0 N9A O-L O9- OAUVE OA~ OK1 OL0 P-8 P-9 P2P PC. Q38 ROL RPZ SDF SEL SES SSZ W8F Z5R 0SF 6I. AACTN AAFTH ABVKL AFCTW AFETI AJOXV AMFUW NCXOZ RIG T5K AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 EFLBG 5PM |
ID | FETCH-LOGICAL-c574t-f41950c0fb700a4d8663528affec891fe78d7fcbdc21903d55a41f477e9ad1e13 |
ISSN | 1936-878X 1876-7591 |
IngestDate | Thu Aug 21 18:19:51 EDT 2025 Fri Sep 05 11:49:40 EDT 2025 Thu Apr 03 07:09:49 EDT 2025 Tue Jul 01 00:39:11 EDT 2025 Thu Apr 24 23:00:15 EDT 2025 Sun Feb 23 10:20:25 EST 2025 Tue Aug 26 16:32:32 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | infiltrative cardiomyopathy myocardial delayed enhancement ECG LVEF CMR ECF LV LGE left ventricular mass T1 mapping amyloid λGd CA myocardial extracellular fraction left ventricular ejection fraction λ Gd electrocardiogram cardiac amyloidosis partition coefficient for gadolinium late gadolinium enhancement left ventricular cardiac magnetic resonance |
Language | English |
License | http://www.elsevier.com/open-access/userlicense/1.0 https://www.elsevier.com/tdm/userlicense/1.0 https://www.elsevier.com/open-access/userlicense/1.0 Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c574t-f41950c0fb700a4d8663528affec891fe78d7fcbdc21903d55a41f477e9ad1e13 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.clinicalkey.com/#!/content/1-s2.0-S1936878X12005323 |
PMID | 22974802 |
PQID | 1039884187 |
PQPubID | 23479 |
PageCount | 11 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3954504 proquest_miscellaneous_1039884187 pubmed_primary_22974802 crossref_citationtrail_10_1016_j_jcmg_2012_04_006 crossref_primary_10_1016_j_jcmg_2012_04_006 elsevier_clinicalkeyesjournals_1_s2_0_S1936878X12005323 elsevier_clinicalkey_doi_10_1016_j_jcmg_2012_04_006 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2012-09-01 |
PublicationDateYYYYMMDD | 2012-09-01 |
PublicationDate_xml | – month: 09 year: 2012 text: 2012-09-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | JACC. Cardiovascular imaging |
PublicationTitleAlternate | JACC Cardiovasc Imaging |
PublicationYear | 2012 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Maceira, Joshi, Prasad (bib4) 2005; 111 Iles, Pfluger, Phrommintikul (bib15) 2008; 52 Falk, Dubrey (bib25) 2010; 52 Ha, Ommen, Tajik (bib24) 2004; 94 Hosch, Kristen, Libicher (bib5) 2008; 15 Arad, Maron, Gorham (bib3) 2005; 352 Vogelsberg, Mahrholdt, Deluigi (bib9) 2008; 51 Rudolph, Abdel-Aty, Bohl (bib12) 2009; 53 Flacke, Fischer, Lorenz (bib26) 2001; 218 Ruberg, Appelbaum, Davidoff (bib7) 2009; 103 Migrino, Christenson, Szabo, Bright, Truran, Hari (bib10) 2009; 9 Austin, Tang, Rodriguez (bib6) 2009; 2 Flett, Hayward, Ashworth (bib21) 2010; 122 Messroghli, Radjenovic, Kozerke, Higgins, Sivananthan, Ridgway (bib14) 2004; 52 Thornhill, Prato, Wisenberg, White, Nowell, Sauer (bib17) 2006; 55 Arheden, Saeed, Higgins (bib18) 1999; 211 Schelbert, Testa, Meier (bib27) 2011; 13 De Cobelli, Esposito, Belloni (bib2) 2009; 192 Karamitsos, Francis, Myerson, Selvanayagam, Neubauer (bib28) 2009; 54 Jerosch-Herold, Sheridan, Kushner (bib19) 2008; 295 Seward, Casaclang-Verzosa (bib1) 2010; 55 Syed, Glockner, Feng (bib8) 2010; 3 Broberg, Chugh, Conklin, Sahn, Jerosch-Herold (bib20) 2010; 3 Piotrowska-Kownacka, Kownacki, Kuch (bib11) 2009; 11 Carroll, Gaasch, McAdam (bib23) 1982; 49 Maceira, Prasad, Hawkins, Roughton, Pennell (bib22) 2008; 10 Thornhill, Prato, Wisenberg, Moran, Sykes (bib16) 2004; 52 Mewton, Liu, Croisille, Bluemke, Lima (bib13) 2011; 57 Falk (10.1016/j.jcmg.2012.04.006_bib25) 2010; 52 Ruberg (10.1016/j.jcmg.2012.04.006_bib7) 2009; 103 Seward (10.1016/j.jcmg.2012.04.006_bib1) 2010; 55 Mewton (10.1016/j.jcmg.2012.04.006_bib13) 2011; 57 Migrino (10.1016/j.jcmg.2012.04.006_bib10) 2009; 9 Thornhill (10.1016/j.jcmg.2012.04.006_bib17) 2006; 55 Karamitsos (10.1016/j.jcmg.2012.04.006_bib28) 2009; 54 Maceira (10.1016/j.jcmg.2012.04.006_bib4) 2005; 111 Vogelsberg (10.1016/j.jcmg.2012.04.006_bib9) 2008; 51 Messroghli (10.1016/j.jcmg.2012.04.006_bib14) 2004; 52 Ha (10.1016/j.jcmg.2012.04.006_bib24) 2004; 94 Flacke (10.1016/j.jcmg.2012.04.006_bib26) 2001; 218 Arad (10.1016/j.jcmg.2012.04.006_bib3) 2005; 352 Austin (10.1016/j.jcmg.2012.04.006_bib6) 2009; 2 Syed (10.1016/j.jcmg.2012.04.006_bib8) 2010; 3 Piotrowska-Kownacka (10.1016/j.jcmg.2012.04.006_bib11) 2009; 11 Broberg (10.1016/j.jcmg.2012.04.006_bib20) 2010; 3 Schelbert (10.1016/j.jcmg.2012.04.006_bib27) 2011; 13 Jerosch-Herold (10.1016/j.jcmg.2012.04.006_bib19) 2008; 295 Flett (10.1016/j.jcmg.2012.04.006_bib21) 2010; 122 Thornhill (10.1016/j.jcmg.2012.04.006_bib16) 2004; 52 Carroll (10.1016/j.jcmg.2012.04.006_bib23) 1982; 49 Rudolph (10.1016/j.jcmg.2012.04.006_bib12) 2009; 53 De Cobelli (10.1016/j.jcmg.2012.04.006_bib2) 2009; 192 Iles (10.1016/j.jcmg.2012.04.006_bib15) 2008; 52 Arheden (10.1016/j.jcmg.2012.04.006_bib18) 1999; 211 Maceira (10.1016/j.jcmg.2012.04.006_bib22) 2008; 10 Hosch (10.1016/j.jcmg.2012.04.006_bib5) 2008; 15 22974803 - JACC Cardiovasc Imaging. 2012 Sep;5(9):908-10. doi: 10.1016/j.jcmg.2012.04.007 |
References_xml | – volume: 352 start-page: 362 year: 2005 end-page: 372 ident: bib3 article-title: Glycogen storage diseases presenting as hypertrophic cardiomyopathy publication-title: N Engl J Med – volume: 2 start-page: 1369 year: 2009 end-page: 1377 ident: bib6 article-title: Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis publication-title: J Am Coll Cardiol Img – volume: 52 start-page: 141 year: 2004 end-page: 146 ident: bib14 article-title: Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart publication-title: Magn Reson Med – volume: 52 start-page: 1069 year: 2004 end-page: 1079 ident: bib16 article-title: Determining the extent to which delayed-enhancement images reflect the partition-coefficient of Gd-DTPA in canine studies of reperfused and unreperfused myocardial infarction publication-title: Magn Reson Med – volume: 54 start-page: 1407 year: 2009 end-page: 1424 ident: bib28 article-title: The role of cardiovascular magnetic resonance imaging in heart failure publication-title: J Am Coll Cardiol – volume: 9 start-page: 5 year: 2009 ident: bib10 article-title: Prognostic implication of late gadolinium enhancement on cardiac MRI in light chain (AL) amyloidosis on long term follow up publication-title: BMC Med Phys – volume: 10 start-page: 54 year: 2008 ident: bib22 article-title: Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis publication-title: J Cardiovasc Magn Reson – volume: 53 start-page: 284 year: 2009 end-page: 291 ident: bib12 article-title: Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling publication-title: J Am Coll Cardiol – volume: 51 start-page: 1022 year: 2008 end-page: 1030 ident: bib9 article-title: Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy publication-title: J Am Coll Cardiol – volume: 122 start-page: 138 year: 2010 end-page: 144 ident: bib21 article-title: Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans publication-title: Circulation – volume: 3 start-page: 727 year: 2010 end-page: 734 ident: bib20 article-title: Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease publication-title: Circ Cardiovasc Imaging – volume: 94 start-page: 316 year: 2004 end-page: 319 ident: bib24 article-title: Differentiation of constrictive pericarditis from restrictive cardiomyopathy using mitral annular velocity by tissue Doppler echocardiography publication-title: Am J Cardiol – volume: 111 start-page: 186 year: 2005 end-page: 193 ident: bib4 article-title: Cardiovascular magnetic resonance in cardiac amyloidosis publication-title: Circulation – volume: 57 start-page: 891 year: 2011 end-page: 903 ident: bib13 article-title: Assessment of myocardial fibrosis with cardiovascular magnetic resonance publication-title: J Am Coll Cardiol – volume: 3 start-page: 155 year: 2010 end-page: 164 ident: bib8 article-title: Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis publication-title: J Am Coll Cardiol Img – volume: 11 start-page: 12 year: 2009 ident: bib11 article-title: Cardiovascular magnetic resonance findings in a case of Danon disease publication-title: J Cardiovasc Magn Reson – volume: 15 start-page: 196 year: 2008 end-page: 204 ident: bib5 article-title: Late enhancement in cardiac amyloidosis: correlation of MRI enhancement pattern with histopathological findings publication-title: Amyloid – volume: 52 start-page: 1574 year: 2008 end-page: 1580 ident: bib15 article-title: Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping publication-title: J Am Coll Cardiol – volume: 49 start-page: 9 year: 1982 end-page: 13 ident: bib23 article-title: Amyloid cardiomyopathy: characterization by a distinctive voltage/mass relation publication-title: Am J Cardiol – volume: 192 start-page: W97 year: 2009 end-page: W102 ident: bib2 article-title: Delayed-enhanced cardiac MRI for differentiation of Fabry's disease from symmetric hypertrophic cardiomyopathy publication-title: AJR Am J Roentgenol – volume: 103 start-page: 544 year: 2009 end-page: 549 ident: bib7 article-title: Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis publication-title: Am J Cardiol – volume: 13 start-page: 16 year: 2011 ident: bib27 article-title: Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus publication-title: J Cardiovasc Magn Reson – volume: 295 start-page: H1234 year: 2008 end-page: H1242 ident: bib19 article-title: Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy publication-title: Am J Physiol Heart Circ Physiol – volume: 218 start-page: 703 year: 2001 end-page: 710 ident: bib26 article-title: Measurement of the gadopentetate dimeglumine partition coefficient in human myocardium in vivo: normal distribution and elevation in acute and chronic infarction publication-title: Radiology – volume: 55 start-page: 1769 year: 2010 end-page: 1779 ident: bib1 article-title: Infiltrative cardiovascular diseases: cardiomyopathies that look alike publication-title: J Am Coll Cardiol – volume: 211 start-page: 698 year: 1999 end-page: 708 ident: bib18 article-title: Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats publication-title: Radiology – volume: 55 start-page: 780 year: 2006 end-page: 789 ident: bib17 article-title: Feasibility of the single-bolus strategy for measuring the partition coefficient of Gd-DTPA in patients with myocardial infarction: independence of image delay time and maturity of scar publication-title: Magn Reson Med – volume: 52 start-page: 347 year: 2010 end-page: 361 ident: bib25 article-title: Amyloid heart disease publication-title: Prog Cardiovasc Dis – volume: 52 start-page: 141 year: 2004 ident: 10.1016/j.jcmg.2012.04.006_bib14 article-title: Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart publication-title: Magn Reson Med doi: 10.1002/mrm.20110 – volume: 49 start-page: 9 year: 1982 ident: 10.1016/j.jcmg.2012.04.006_bib23 article-title: Amyloid cardiomyopathy: characterization by a distinctive voltage/mass relation publication-title: Am J Cardiol doi: 10.1016/0002-9149(82)90270-3 – volume: 57 start-page: 891 year: 2011 ident: 10.1016/j.jcmg.2012.04.006_bib13 article-title: Assessment of myocardial fibrosis with cardiovascular magnetic resonance publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2010.11.013 – volume: 52 start-page: 1574 year: 2008 ident: 10.1016/j.jcmg.2012.04.006_bib15 article-title: Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2008.06.049 – volume: 53 start-page: 284 year: 2009 ident: 10.1016/j.jcmg.2012.04.006_bib12 article-title: Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2008.08.064 – volume: 94 start-page: 316 year: 2004 ident: 10.1016/j.jcmg.2012.04.006_bib24 article-title: Differentiation of constrictive pericarditis from restrictive cardiomyopathy using mitral annular velocity by tissue Doppler echocardiography publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2004.04.026 – volume: 111 start-page: 186 year: 2005 ident: 10.1016/j.jcmg.2012.04.006_bib4 article-title: Cardiovascular magnetic resonance in cardiac amyloidosis publication-title: Circulation doi: 10.1161/01.CIR.0000152819.97857.9D – volume: 55 start-page: 1769 year: 2010 ident: 10.1016/j.jcmg.2012.04.006_bib1 article-title: Infiltrative cardiovascular diseases: cardiomyopathies that look alike publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2009.12.040 – volume: 352 start-page: 362 year: 2005 ident: 10.1016/j.jcmg.2012.04.006_bib3 article-title: Glycogen storage diseases presenting as hypertrophic cardiomyopathy publication-title: N Engl J Med doi: 10.1056/NEJMoa033349 – volume: 211 start-page: 698 year: 1999 ident: 10.1016/j.jcmg.2012.04.006_bib18 article-title: Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats publication-title: Radiology doi: 10.1148/radiology.211.3.r99jn41698 – volume: 55 start-page: 780 year: 2006 ident: 10.1016/j.jcmg.2012.04.006_bib17 article-title: Feasibility of the single-bolus strategy for measuring the partition coefficient of Gd-DTPA in patients with myocardial infarction: independence of image delay time and maturity of scar publication-title: Magn Reson Med doi: 10.1002/mrm.20830 – volume: 54 start-page: 1407 year: 2009 ident: 10.1016/j.jcmg.2012.04.006_bib28 article-title: The role of cardiovascular magnetic resonance imaging in heart failure publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2009.04.094 – volume: 192 start-page: W97 year: 2009 ident: 10.1016/j.jcmg.2012.04.006_bib2 article-title: Delayed-enhanced cardiac MRI for differentiation of Fabry's disease from symmetric hypertrophic cardiomyopathy publication-title: AJR Am J Roentgenol doi: 10.2214/AJR.08.1201 – volume: 51 start-page: 1022 year: 2008 ident: 10.1016/j.jcmg.2012.04.006_bib9 article-title: Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2007.10.049 – volume: 52 start-page: 1069 year: 2004 ident: 10.1016/j.jcmg.2012.04.006_bib16 article-title: Determining the extent to which delayed-enhancement images reflect the partition-coefficient of Gd-DTPA in canine studies of reperfused and unreperfused myocardial infarction publication-title: Magn Reson Med doi: 10.1002/mrm.20236 – volume: 295 start-page: H1234 year: 2008 ident: 10.1016/j.jcmg.2012.04.006_bib19 article-title: Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy publication-title: Am J Physiol Heart Circ Physiol doi: 10.1152/ajpheart.00429.2008 – volume: 9 start-page: 5 year: 2009 ident: 10.1016/j.jcmg.2012.04.006_bib10 article-title: Prognostic implication of late gadolinium enhancement on cardiac MRI in light chain (AL) amyloidosis on long term follow up publication-title: BMC Med Phys doi: 10.1186/1756-6649-9-5 – volume: 122 start-page: 138 year: 2010 ident: 10.1016/j.jcmg.2012.04.006_bib21 article-title: Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.109.930636 – volume: 13 start-page: 16 year: 2011 ident: 10.1016/j.jcmg.2012.04.006_bib27 article-title: Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus publication-title: J Cardiovasc Magn Reson doi: 10.1186/1532-429X-13-16 – volume: 218 start-page: 703 year: 2001 ident: 10.1016/j.jcmg.2012.04.006_bib26 article-title: Measurement of the gadopentetate dimeglumine partition coefficient in human myocardium in vivo: normal distribution and elevation in acute and chronic infarction publication-title: Radiology doi: 10.1148/radiology.218.3.r01fe18703 – volume: 3 start-page: 155 year: 2010 ident: 10.1016/j.jcmg.2012.04.006_bib8 article-title: Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis publication-title: J Am Coll Cardiol Img doi: 10.1016/j.jcmg.2009.09.023 – volume: 11 start-page: 12 year: 2009 ident: 10.1016/j.jcmg.2012.04.006_bib11 article-title: Cardiovascular magnetic resonance findings in a case of Danon disease publication-title: J Cardiovasc Magn Reson doi: 10.1186/1532-429X-11-12 – volume: 10 start-page: 54 year: 2008 ident: 10.1016/j.jcmg.2012.04.006_bib22 article-title: Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis publication-title: J Cardiovasc Magn Reson doi: 10.1186/1532-429X-10-54 – volume: 52 start-page: 347 year: 2010 ident: 10.1016/j.jcmg.2012.04.006_bib25 article-title: Amyloid heart disease publication-title: Prog Cardiovasc Dis doi: 10.1016/j.pcad.2009.11.007 – volume: 103 start-page: 544 year: 2009 ident: 10.1016/j.jcmg.2012.04.006_bib7 article-title: Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2008.09.105 – volume: 3 start-page: 727 year: 2010 ident: 10.1016/j.jcmg.2012.04.006_bib20 article-title: Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease publication-title: Circ Cardiovasc Imaging doi: 10.1161/CIRCIMAGING.108.842096 – volume: 15 start-page: 196 year: 2008 ident: 10.1016/j.jcmg.2012.04.006_bib5 article-title: Late enhancement in cardiac amyloidosis: correlation of MRI enhancement pattern with histopathological findings publication-title: Amyloid doi: 10.1080/13506120802193233 – volume: 2 start-page: 1369 year: 2009 ident: 10.1016/j.jcmg.2012.04.006_bib6 article-title: Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis publication-title: J Am Coll Cardiol Img doi: 10.1016/j.jcmg.2009.08.008 – reference: 22974803 - JACC Cardiovasc Imaging. 2012 Sep;5(9):908-10. doi: 10.1016/j.jcmg.2012.04.007 |
SSID | ssj0060647 |
Score | 2.3790004 |
Snippet | The aim of this study was to perform direct quantification of myocardial extracellular volume fraction (ECF) with T1-weighted cardiac magnetic resonance (CMR)... Objectives The aim of this study was to perform direct quantification of myocardial extracellular volume fraction (ECF) with T1-weighted cardiac magnetic... |
SourceID | pubmedcentral proquest pubmed crossref elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 897 |
SubjectTerms | Aged Aged, 80 and over amyloid Amyloidosis - pathology Biopsy Cardiomyopathies - pathology Cardiovascular Chi-Square Distribution Contrast Media Cross-Sectional Studies Extracellular Matrix - pathology Gadolinium DTPA Humans infiltrative cardiomyopathy left ventricular mass Linear Models Lysosomal Storage Diseases - pathology Magnetic Resonance Imaging, Cine Middle Aged myocardial delayed enhancement Myocardium - pathology Predictive Value of Tests Retrospective Studies Severity of Illness Index T1 mapping |
Title | Quantification of Extracellular Matrix Expansion by CMR in Infiltrative Heart Disease |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1936878X12005323 https://www.clinicalkey.es/playcontent/1-s2.0-S1936878X12005323 https://www.ncbi.nlm.nih.gov/pubmed/22974802 https://www.proquest.com/docview/1039884187 https://pubmed.ncbi.nlm.nih.gov/PMC3954504 |
Volume | 5 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb5swFLaiTpr2Mu2-7CYm7a0iMmBi81hFrbJK2SVrpL4hYnBDlsLUkKnLw_7M_ujOscElaVqteyER2A5wvvgcDp-_Q8iHRE1DGijqKhVSl_lSuZHioUsz6SMNAyJuzfL91B9O2PFpeNrp_GmxllbVtCfXO9eV_I9VYR_YFVfJ3sGydlDYAd_BvrAFC8P2n2z8dZUYro-N-w4vq4sEk_GaXTpC_f1LlDMGh4QtINYcjMaY4_hYqHxR1bLfQ4B7hUKc9l1NE64eDAY9JIVscFbPdWUja6qyOMtKGwXrN--8zJfuF_C4V9Ta4wx1M2fuED5NMrrN2NcLRbLFrHSPctji4c-VHsr7mZf743y9zm3mYJEU35dNlc5xjas6c4EUkKjJXJjJNkIxZK5LC9vZOGyBLmrNrMLQeGsnHZlSudfmf5OKmPfm8vwMeXu-1rGlO8S2t5ygpSY2rLd5jGPEOEZMWaxl3e_5nGsuQO-35RH1cbWuoS6Yi6lXZhkS4fZ53BT9XH-62SbptqKek0fkYf244hwY7D0mnax4Qu6PakLGUzLZhKBTKmcDgo6BoGMh6Ex_OQBBJy-cNgQdDUGnhuAzMjk6PBkM3bpShytDzipXMawmLKmackoTlgqMY32RICVJRJ7KuEi5ktNUgoOkQRqGCfMU4zyLktTLvOA52SvKIntJHD8SMFASBBKdC0sS6adCyH6UCpbKNOgSr7mDsaxl7LGayiK-2XJdsm_7_DAiLre2DhrDxM3yZHCoMWDs1l58V69sWc8Xy9iLl9A4_oZIQaB4mNANfLii9431Y5jb0UBJkZUr6EGDSAjmCd4lLwwa7Pn7fsSZoD787gZObAPUjd88UuQzrR8fRPDYRNmrO92V1-TB1X_4DdmrLlbZW4jHq-k7_X_4C6SQ4gU |
linkProvider | Elsevier |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Quantification+of+Extracellular+Matrix+Expansion+by+CMR+in+Infiltrative+Heart+Disease&rft.jtitle=JACC.+Cardiovascular+imaging&rft.au=Mongeon%2C+Fran%C3%A7ois-Pierre&rft.au=Jerosch-Herold%2C+Michael&rft.au=Coelho-Filho%2C+Ot%C3%A1vio+Rizzi&rft.au=Blankstein%2C+Ron&rft.date=2012-09-01&rft.issn=1936-878X&rft.volume=5&rft.issue=9&rft.spage=897&rft.epage=907&rft_id=info:doi/10.1016%2Fj.jcmg.2012.04.006&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_jcmg_2012_04_006 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F1936878X%2FS1936878X11X00219%2Fcov150h.gif |